Showing results (151-160 of 451) with videos related to
Sort By:
Pageof 46
Nature Reviews. Rheumatology|February 27, 2020
Raynaud phenomenon and digital ulcers in systemic sclerosisMichael Hughes, Yannick Allanore, Lorinda Chung, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2025
Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Course of Interstitial Lung Disease in Patients With Systemic SclerosisShervin Assassi, Christopher P Denton, Matthias Zwick, et al.Rheumatology (Oxford, England)|July 9, 2013
Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factorsEmma C Derrett-Smith, Svetlana I Nihtyanova, Jennifer Harvey, et al.Journal of Scleroderma and Related Disorders|June 8, 2023
A purple plaque in a patient with systemic sclerosisSheena Ramyead, Christopher P Denton, Catherine H Orteu, et al.The American Journal of Cardiology|January 8, 2013
Clinical characteristics, haemodynamics and treatment of pulmonary hypertension in sarcoidosis in a single centre, and meta-analysis of the published dataDavid Dobarro, Benjamin Emmanuel Schreiber, Clive Handler, et al.Clinical and Experimental Rheumatology|October 18, 2016
UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisisBernadette M Lynch, Edward P Stern, Voon Ong, et al.Arthritis Research & Therapy|October 7, 2005
Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosisVineeth S Rajkumar, Kevin Howell, Katalin Csiszar, et al.Rheumatology (Oxford, England)|December 17, 2009
Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblastsXu Shi-wen, Mark Eastwood, Richard J Stratton, et al.Archives of Dermatological Research|March 13, 2023
Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsiesAmanda M Saracino, Daniel Kelberman, Georg W Otto, et al.Current Opinion in Rheumatology|September 20, 2022
Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culpritVishal Kakkar, Shervin Assassi, Yannick Allanore, et al.Pageof 46